Report: J&J Concealed Flawed Test Results in Xarelto Trial
New information recently came out that could be used to help bolster the cases of plaintiffs in...
READ MOREThe dangerous risks associated with a popular blood thinner medication have been hidden in the shadows for far too long, and it’s time for you to know the truth. Our Xarelto lawyers are currently talking to patients who have been harmed by the popular blood thinner Xarelto. Xarelto is a blockbuster drug that may come with a heavy price tag: severe internal bleeding an increased risk of kidney and liver damage, stroke, severe internal bleeding or even death.
To see if you have a Xarelto lawsuit, contact Baron & Budd at 866-520-2755 or contact us online to see if you qualify.
[checklist circle=”no” icon=”fa-angle-right” iconcolor=”#222″]
[/checklist]
The dangerous risk of internal bleeding that comes with taking Xarelto can be so severe that patients are required to undergo extensive hospitalization or may even face serious risk of death.
Xarelto is manufactured by Bayer and marketed by Johnson & Johnson subsidiary Janssen Pharmaceuticals. These are international, multi-billion dollar corporations, that patients and doctors have given so much trust to over the years. So, one would think, if internal bleeding was a risk factor of taking Xarelto, both Bayer and Johnson & Johnson would have done everything in their power (— now, remember these two companies have a lot of power!) to educate both doctors and patients and alert the FDA about potential serious side effects.
We have found that while all blood thinners may carry a risk of internal bleeding, the risk of internal bleeding that comes with Xarelto may be worse than other blood thinners on the market.
For example if internal bleeding occurs while a person is taking Warfarin, a doctor can give the patient frozen plasma or high doses of vitamin K to lessen the symptoms and stop the bleeding. Unfortunately, doctors do not have such options for Xarelto, because there are no treatments that seem to stop the bleeding. Instead patients “simply” have to allow the medicine to run its course and hope that any internal bleeding that occurs subsides quickly. Even tests to measure the blood’s clotting ability have given dangerous false positives to people taking blood thinners.
Now that concerns us here at Baron and Budd. What about you?